Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
abiraterone (AST-2970) / Austhera Biosci
NCT04291664: PK and Dose Escalation and Expansion Study of DST-2970	Terminated	1	26	US	Abiraterone Acetate, Prednisone 5Mg Tab, DST-2970 (Abiraterone)	DisperSol Technologies, LLC, Translational Drug Development	Prostate Cancer	01/23	01/23